351 related articles for article (PubMed ID: 8576447)
1. Subsets of midbrain dopaminergic neurons in monkeys are distinguished by different levels of mRNA for the dopamine transporter: comparison with the mRNA for the D2 receptor, tyrosine hydroxylase and calbindin immunoreactivity.
Haber SN; Ryoo H; Cox C; Lu W
J Comp Neurol; 1995 Nov; 362(3):400-10. PubMed ID: 8576447
[TBL] [Abstract][Full Text] [Related]
2. Dopaminergic neurons in rat ventral midbrain express brain-derived neurotrophic factor and neurotrophin-3 mRNAs.
Seroogy KB; Lundgren KH; Tran TM; Guthrie KM; Isackson PJ; Gall CM
J Comp Neurol; 1994 Apr; 342(3):321-34. PubMed ID: 7912699
[TBL] [Abstract][Full Text] [Related]
3. Differential modification of dopamine transporter and tyrosine hydroxylase mRNAs in midbrain of subjects with Parkinson's, Alzheimer's with parkinsonism, and Alzheimer's disease.
Joyce JN; Smutzer G; Whitty CJ; Myers A; Bannon MJ
Mov Disord; 1997 Nov; 12(6):885-97. PubMed ID: 9399211
[TBL] [Abstract][Full Text] [Related]
4. Tyrosine hydroxylase and dopamine transporter expression following 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurodegeneration of the mouse nigrostriatal pathway.
Jakowec MW; Nixon K; Hogg E; McNeill T; Petzinger GM
J Neurosci Res; 2004 May; 76(4):539-50. PubMed ID: 15114626
[TBL] [Abstract][Full Text] [Related]
5. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.
Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T
Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626
[TBL] [Abstract][Full Text] [Related]
6. Tyrosine hydroxylase and dopamine transporter expression in residual dopaminergic neurons: potential contributors to spontaneous recovery from experimental Parkinsonism.
Rothblat DS; Schroeder JA; Schneider JS
J Neurosci Res; 2001 Aug; 65(3):254-66. PubMed ID: 11494360
[TBL] [Abstract][Full Text] [Related]
7. Differential survival patterns among midbrain dopaminergic cells of MPTP-treated monkeys and 6OHDA-lesioned rats.
Fitzpatrick E; Ashkan K; Wallace BA; Benabid AL; Mitrofanis J
Anat Embryol (Berl); 2005 Sep; 210(2):101-23. PubMed ID: 16151853
[TBL] [Abstract][Full Text] [Related]
8. Reduced gene expression for dopamine biosynthesis and transport in midbrain neurons of adult male rats exposed prenatally to ethanol.
Szot P; White SS; Veith RC; Rasmussen DD
Alcohol Clin Exp Res; 1999 Oct; 23(10):1643-9. PubMed ID: 10549997
[TBL] [Abstract][Full Text] [Related]
9. Dopamine transporter messenger RNA in Parkinson's disease and control substantia nigra neurons.
Uhl GR; Walther D; Mash D; Faucheux B; Javoy-Agid F
Ann Neurol; 1994 Apr; 35(4):494-8. PubMed ID: 8154880
[TBL] [Abstract][Full Text] [Related]
10. Subcellular localization and molecular topology of the dopamine transporter in the striatum and substantia nigra.
Hersch SM; Yi H; Heilman CJ; Edwards RH; Levey AI
J Comp Neurol; 1997 Nov; 388(2):211-27. PubMed ID: 9368838
[TBL] [Abstract][Full Text] [Related]
11. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
[TBL] [Abstract][Full Text] [Related]
12. Subpopulations of mesencephalic dopaminergic neurons express different levels of tyrosine hydroxylase messenger RNA.
Weiss-Wunder LT; Chesselet MF
J Comp Neurol; 1991 Jan; 303(3):478-88. PubMed ID: 1672536
[TBL] [Abstract][Full Text] [Related]
13. Delayed plasticity of the mesolimbic dopamine system following neonatal 6-OHDA lesions.
Frohna PA; Neal-Beliveau BS; Joyce JN
Synapse; 1997 Mar; 25(3):293-305. PubMed ID: 9068128
[TBL] [Abstract][Full Text] [Related]
14. Neurochemical characterization of dopaminergic neurons in human striatum.
Cossette M; Lévesque D; Parent A
Parkinsonism Relat Disord; 2005 Aug; 11(5):277-86. PubMed ID: 15970454
[TBL] [Abstract][Full Text] [Related]
15. Adrenalectomy counteracts the local modulation of astroglial fibroblast growth factor system without interfering with the pattern of 6-OHDA-induced dopamine degeneration in regions of the ventral midbrain.
Chadi G; Silva C; Maximino JR; Fuxe K; da Silva GO
Brain Res; 2008 Jan; 1190():23-38. PubMed ID: 18086466
[TBL] [Abstract][Full Text] [Related]
16. Absence of MPTP-induced neuronal death in mice lacking the dopamine transporter.
Bezard E; Gross CE; Fournier MC; Dovero S; Bloch B; Jaber M
Exp Neurol; 1999 Feb; 155(2):268-73. PubMed ID: 10072302
[TBL] [Abstract][Full Text] [Related]
17. Expression of N-methyl-D-aspartate receptor subunit mRNA in the human brain: mesencephalic dopaminergic neurons.
Counihan TJ; Landwehrmeyer GB; Standaert DG; Kosinski CM; Scherzer CR; Daggett LP; Veliçelebi G; Young AB; Penney JB
J Comp Neurol; 1998 Jan; 390(1):91-101. PubMed ID: 9456178
[TBL] [Abstract][Full Text] [Related]
18. Expression of dopamine and vesicular monoamine transporters and differential vulnerability of mesostriatal dopaminergic neurons.
González-Hernández T; Barroso-Chinea P; De La Cruz Muros I; Del Mar Pérez-Delgado M; Rodríguez M
J Comp Neurol; 2004 Nov; 479(2):198-215. PubMed ID: 15452855
[TBL] [Abstract][Full Text] [Related]
19. Ventral mesencephalic neurons containing both cholecystokinin- and tyrosine hydroxylase-like immunoreactivities project to forebrain regions.
Seroogy KB; Dangaran K; Lim S; Haycock JW; Fallon JH
J Comp Neurol; 1989 Jan; 279(3):397-414. PubMed ID: 2563737
[TBL] [Abstract][Full Text] [Related]
20. Dopamine innervation of the monkey mediodorsal thalamus: Location of projection neurons and ultrastructural characteristics of axon terminals.
Melchitzky DS; Erickson SL; Lewis DA
Neuroscience; 2006 Dec; 143(4):1021-30. PubMed ID: 17029800
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
